Averna Therapeutics

Developer of RNAand lipid nanoparticle-based genomic medicines to treat multiple diseases by inserting genes

placeWatertown, Massachusetts, United States calendar_todayFounded 2024 language avernatx.com

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 10 times.

YearFilings
20253
20261

Investor mix

10 investors on record; lead investors include Novartis Venture Fund, Delos Capital.

Investor typeCountShare
Venture capital440%
Private equity440%
Bank & private debt110%
Other / undisclosed110%
Coming soon